div class=ts-pagebutton class=gotoPage data-page=1Page 1button div class=ts-imageimg data-url=ww2fdagovph-circular-no-2018-014pdf-fda-circular-2018-014-no-subject-pursuanthtmlpage=1 data-page=1 class=ts-thumb lazyload alt=Page 1: ww2fdagovph Circular No 2018-014pdf · FDA CIRCULAR 2018-014 No SUBJECT: Pursuant to the strategies and directives of the Center for Drug Regulation and Research CDRR to streamline loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentinreader030viewer20220407095e0e0e16b2ad183e08184c79html5thumbnails1jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=2Page 2button div class=ts-imageimg data-url=ww2fdagovph-circular-no-2018-014pdf-fda-circular-2018-014-no-subject-pursuanthtmlpage=2 data-page=2 class=ts-thumb lazyload alt=Page 2: ww2fdagovph Circular No 2018-014pdf · FDA CIRCULAR 2018-014 No SUBJECT: Pursuant to the strategies and directives of the Center for Drug Regulation and Research CDRR to streamline loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentinreader030viewer20220407095e0e0e16b2ad183e08184c79html5thumbnails2jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=3Page 3button div class=ts-imageimg data-url=ww2fdagovph-circular-no-2018-014pdf-fda-circular-2018-014-no-subject-pursuanthtmlpage=3 data-page=3 class=ts-thumb lazyload alt=Page 3: ww2fdagovph Circular No 2018-014pdf · FDA CIRCULAR 2018-014 No SUBJECT: Pursuant to the strategies and directives of the Center for Drug Regulation and Research CDRR to streamline loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentinreader030viewer20220407095e0e0e16b2ad183e08184c79html5thumbnails3jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=4Page 4button div class=ts-imageimg data-url=ww2fdagovph-circular-no-2018-014pdf-fda-circular-2018-014-no-subject-pursuanthtmlpage=4 data-page=4 class=ts-thumb lazyload alt=Page 4: ww2fdagovph Circular No 2018-014pdf · FDA CIRCULAR 2018-014 No SUBJECT: Pursuant to the strategies and directives of the Center for Drug Regulation and Research CDRR to streamline loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentinreader030viewer20220407095e0e0e16b2ad183e08184c79html5thumbnails4jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=5Page 5button div class=ts-imageimg data-url=ww2fdagovph-circular-no-2018-014pdf-fda-circular-2018-014-no-subject-pursuanthtmlpage=5 data-page=5 class=ts-thumb lazyload alt=Page 5: ww2fdagovph Circular No 2018-014pdf · FDA CIRCULAR 2018-014 No SUBJECT: Pursuant to the strategies and directives of the Center for Drug Regulation and Research CDRR to streamline loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentinreader030viewer20220407095e0e0e16b2ad183e08184c79html5thumbnails5jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=6Page 6button div class=ts-imageimg data-url=ww2fdagovph-circular-no-2018-014pdf-fda-circular-2018-014-no-subject-pursuanthtmlpage=6 data-page=6 class=ts-thumb lazyload alt=Page 6: ww2fdagovph Circular No 2018-014pdf · FDA CIRCULAR 2018-014 No SUBJECT: Pursuant to the strategies and directives of the Center for Drug Regulation and Research CDRR to streamline loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentinreader030viewer20220407095e0e0e16b2ad183e08184c79html5thumbnails6jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=7Page 7button div class=ts-imageimg data-url=ww2fdagovph-circular-no-2018-014pdf-fda-circular-2018-014-no-subject-pursuanthtmlpage=7 data-page=7 class=ts-thumb lazyload alt=Page 7: ww2fdagovph Circular No 2018-014pdf · FDA CIRCULAR 2018-014 No SUBJECT: Pursuant to the strategies and directives of the Center for Drug Regulation and Research CDRR to streamline loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentinreader030viewer20220407095e0e0e16b2ad183e08184c79html5thumbnails7jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=8Page 8button div class=ts-imageimg data-url=ww2fdagovph-circular-no-2018-014pdf-fda-circular-2018-014-no-subject-pursuanthtmlpage=8 data-page=8 class=ts-thumb lazyload alt=Page 8: ww2fdagovph Circular No 2018-014pdf · FDA CIRCULAR 2018-014 No SUBJECT: Pursuant to the strategies and directives of the Center for Drug Regulation and Research CDRR to streamline loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentinreader030viewer20220407095e0e0e16b2ad183e08184c79html5thumbnails8jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=9Page 9button div class=ts-imageimg data-url=ww2fdagovph-circular-no-2018-014pdf-fda-circular-2018-014-no-subject-pursuanthtmlpage=9 data-page=9 class=ts-thumb lazyload alt=Page 9: ww2fdagovph Circular No 2018-014pdf · FDA CIRCULAR 2018-014 No SUBJECT: Pursuant to the strategies and directives of the Center for Drug Regulation and Research CDRR to streamline loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentinreader030viewer20220407095e0e0e16b2ad183e08184c79html5thumbnails9jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=10Page 10button div class=ts-imageimg data-url=ww2fdagovph-circular-no-2018-014pdf-fda-circular-2018-014-no-subject-pursuanthtmlpage=10 data-page=10 class=ts-thumb lazyload alt=Page 10: ww2fdagovph Circular No 2018-014pdf · FDA CIRCULAR 2018-014 No SUBJECT: Pursuant to the strategies and directives of the Center for Drug Regulation and Research CDRR to streamline loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentinreader030viewer20220407095e0e0e16b2ad183e08184c79html5thumbnails10jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=11Page 11button div class=ts-imageimg data-url=ww2fdagovph-circular-no-2018-014pdf-fda-circular-2018-014-no-subject-pursuanthtmlpage=11 data-page=11 class=ts-thumb lazyload alt=Page 11: ww2fdagovph Circular No 2018-014pdf · FDA CIRCULAR 2018-014 No SUBJECT: Pursuant to the strategies and directives of the Center for Drug Regulation and Research CDRR to streamline loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentinreader030viewer20220407095e0e0e16b2ad183e08184c79html5thumbnails11jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=12Page 12button div class=ts-imageimg data-url=ww2fdagovph-circular-no-2018-014pdf-fda-circular-2018-014-no-subject-pursuanthtmlpage=12 data-page=12 class=ts-thumb lazyload alt=Page 12: ww2fdagovph Circular No 2018-014pdf · FDA CIRCULAR 2018-014 No SUBJECT: Pursuant to the strategies and directives of the Center for Drug Regulation and Research CDRR to streamline loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentinreader030viewer20220407095e0e0e16b2ad183e08184c79html5thumbnails12jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=13Page 13button div class=ts-imageimg data-url=ww2fdagovph-circular-no-2018-014pdf-fda-circular-2018-014-no-subject-pursuanthtmlpage=13 data-page=13 class=ts-thumb lazyload alt=Page 13: ww2fdagovph Circular No 2018-014pdf · FDA CIRCULAR 2018-014 No SUBJECT: Pursuant to the strategies and directives of the Center for Drug Regulation and Research CDRR to streamline loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentinreader030viewer20220407095e0e0e16b2ad183e08184c79html5thumbnails13jpg width=140 height=200 divdiv
